SEARCH

SEARCH BY CITATION

References

  • 1
    . Paulus HE: Nonsteroidal anti-inflammatory drugs, Textbook of Rheumatology. Third edition. Edited by WN.Kelley, ED.HarrisJr, RuddyS, CB.Sledge. Philadelphia, WB Saunders, 1989
  • 2
    . Harris ED Jr: Pathogenesis of rheumatoid arthritis and the development of rational drug therapy. J Rheumatol 9: 39, 1982
  • 3
    . Wright V, Amos R: Do drugs change the course of rheumatoid arthritis? Br Med J 280: 964966, 1980
  • 4
    . Dawes PT, Fowler PD, Clarke S, Fisher J, Lawton A, Shadforth MF: Rheumatoid arthritis: treatment which controls the C-reactive protein and erythrocyte sedimentation rate reduces radiological progression. Br J Rheumatol 25: 4449, 1986
  • 5
    . Wernick R, Merryman P, Jaffe I, Ziff M: IgG and IgM rheumatoid factors in rheumatoid arthritis: quantitative response to penicillamine therapy and relationship to disease activity. Arthritis Rheum 26: 593598, 1983
  • 6
    . Dixon JS, Bird HA, Sitton NG, Pickup ME, Wright V: C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol 13: 3944, 1984
  • 7
    . McConkey B, Crockson RA, Crockson AP, Wilkinson AR: The effects of some anti-inflammatory drugs on the acute phase proteins in rheumatoid arthritis. Q J Med 42: 785791, 1973
  • 8
    . Aylward M, Maddock J, Wheeldon R, Parker RJ: A study of the influence of antirheumatic drug regimens on serum acute-phase proteins, plasma tryptophan, and erythrocyte sedimentation rate in rheumatoid arthritis. Rheumatol Rehabil 14: 101114, 1975
  • 9
    . The Cooperating Clinics Committee of the American Rheumatism Association:A three month trial of indomethacin in rheumatoid arthritis, with special reference to analysis and inference. Clin Pharmacol Ther 8: 1137, 1967
  • 10
    . Scott DL, Dawes PT, Fowler PD, Grindulis KA, Shadforth M, Bacon PA: Antirheumatic drugs and joint damage in rheumatoid arthritis. Q J Med 54: 4959, 1985
  • 11
    . Ceuppens JL, Rodriguez MA, Goodwin JS: Nonsteroidal anti-inflammatory agents inhibit the synthesis of IgM rheumatoid factor in vitro. Lancet I: 528530, 1982
  • 12
    . Spiers EM, Tavendale A, MacConnachie A, Swanson Beck J: The effect of non-steroidal anti-inflammatory drugs on phytohaemagglutinin stimulated lymphocytes: relevance to possible therapeutic immunosuppression by fenclofenac. Int J Immunopharmacol 10: 261269, 1988
  • 13
    . Levy J: Enhancement of deficient T-cell function in rheumatoid arthritis by tolmetin sodium. J Clin Pharmacol 23: 324328, 1983
  • 14
    . Ceuppens JL, Robaeys G, Verdickt W, Vertessen S, Deckmyn H, Dequeker J: Immunomodulatory effects of treatment with naproxen in patients with rheumatic disease. Arthritis Rheum 29: 305311, 1986
  • 15
    . Thoen J, Helgetveit K, Førre ø, Haile Y, Kass E: Effects of piroxicam and D-penicillamine on T lymphocyte subpopulations, natural killer cells, and rheumatoid factor production in rheumatoid arthritis. Scand J Rheumatol 17: 91102, 1988
  • 16
    . Goodwin JS, Ceuppens JL, Rodriguez MA: Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis: effects on indexes of cellular immune status and serum rheumatoid factor levels. JAMA 250: 24852488, 1983
  • 17
    . Blechman WJ, Schmid FR, April PA, Wilson C, Brooks CD: Ibuprofen or aspirin in rheumatoid arthritis therapy? JAMA 233: 336340, 1975
  • 18
    . Waltham-Weeks CD: Etodolac versus naproxen in rheumatoid arthritis: a double-blind crossover study. Curr Med Res Opin 10: 540547, 1987
  • 19
    .Førre ø, Thoen J, Helgetveit K, Haile Y: Non-steroidal anti-inflammatory drugs in rheumatoid arthritis: effects on clinical parameters and cellular immunity. Inflammation 8 (suppl): S109S113, 1984
  • 20
    . Katona G: Fenclofenac: a new nonsteroidal antiinflammatory drug with an immunomodulatory effect in the treatment of active rheumatoid arthritis. Curr Ther Res 37: 5869, 1985
  • 21
    . Ropes MW, Bennett GA, Cobb S, Jacox R, Jessar RA: 1958 revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9: 175176, 1958
  • 22
    . Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315324, 1988
  • 23
    . Cush JJ, Lipsky PE, Postlethwaite AE, Schrohenloher RE, Saway A, Koopman WJ: Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis. Arthritis Rheum 33: 1928, 1990
  • 24
    . ARA Glossary Committee of the American Rheumatism Association:Signs and Symptoms: Dictionary of the Rheumatic Diseases. New York, Contact Associates International, 1982
  • 25
    . Herzenberg LA, Herzenberg LA: Analysis and separation using the fluorescence-activated cell sorter, Handbook of Experimental Immunology. Edited by DM.Weir. Oxford, Blackwell Scientific, 1978
  • 26
    . Olsen NJ, Jasin HE: Decreased pokeweed mitogeninduced IgM and IgM rheumatoid factor synthesis in rheumatoid arthritis patients treated with gold sodium thiomalate or penicillamine. Arthritis Rheum 27: 985994, 1984
  • 27
    . Olsen N, Ziff M, Jasin HE: In vitro synthesis of immunoglobulins and IgM-rheumatoid factor by blood mononuclear cells of patients with rheumatoid arthritis. Rheumatol Int 2: 5966, 1982
  • 28
    . Hick MJ, Heick M, Finely P, Gall EP, Minnich L, Williams RJ: Rheumatoid factor activity by rate nephelometry correlated with clinical activity in rheumatoid arthritis. Am J Clin Pathol 78: 342345, 1982
  • 29
    . Rodriguez MA, Baroja ML, Leon-Ponte M, Stekman IL, Abadi I: Down-regulation of immunoglobulin and IgM-rheumatoid factor synthesis by oral treatment of rheumatoid arthritis patients with a nonsteroidal antiinflammatory drug. Rheumatol Int 8: 8186, 1988
  • 30
    . Cush JJ, Lipsky PE: Phenotypic analysis of synovial tissue and peripheral blood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 31: 12301238, 1988
  • 31
    . Malone DG, Wahl SM, Tsokos M, Cattell H, Decker JL, Wilder RL: Immune function in severe, active rheumatoid arthritis: a relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics. J Clin Invest 74: 11731185, 1984
  • 32
    . Klareskog L, Forsum U, Scheynius A, Kabelitz D, Wigzell H: Evidence in support of a self-perpetuating HLA-DR dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci USA 79: 36323636, 1982
  • 33
    . Poulter LW, Duke O, Panayi GS, Hobbs S, Raferty MJ, Janossy G: Activated T lymphocytes of the synovial membrane in rheumatoid arthritis and other arthropathies. Scand J Immunol 22: 683690, 1985
  • 34
    . Burmester GR, Yu DTY, Irani A-M, Kunkel HG, Winchester RJ: Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis. Arthritis Rheum 24: 13701376, 1981
  • 35
    . Walters MT, Smith JL, Moore K, Evans PR, Cawley MID: An investigation of the action of the disease modifying antirheumatic drugs on the rheumatoid synovial membrane: reduction in T lymphocyte subpopulations and HLA-DP and DQ antigen expression after gold or penicillamine therapy. Ann Rheum Dis 46: 716, 1987
  • 36
    . Burns GF, Battye FL, Goldstein G: Surface antigen changes occurring in short-term cultures of activated human T lymphocytes: analysis by flow cytometry. Cell Immunol 17: 1226, 1982
  • 37
    . Weyand CM, Goronzy J, Fathman CG: Modulation of CD4 by antigenic activation. J Immunol 138: 13511354, 1987
  • 38
    . Matsui Y: Increased density of class I major histocompatibility complex antigens in the early stages of T-cell activation. Hum Immunol 18: 123133, 1987
  • 39
    . Olsen NJ, Callahan LF, Pincus T: Immunologic studies of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 30: 481488, 1987
  • 40
    . Olsen NJ, Jasin HE: Synthesis of rheumatoid factor in vitro: implications for the pathogenesis of rheumatoid arthritis. Semin Arthritis Rheum 15: 146156, 1985
  • 41
    . Olsen NJ, Callahan LF, Pincus T: In vitro rheumatoid factor synthesis in patients taking second-line drugs for rheumatoid arthritis: independent associations with disease activity. Arthritis Rheum 31: 10901096, 1988